As of 2024-07-27, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is 14.82 USD. This relative valuation is based on P/E multiples. With the latest stock price at 63.25 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -76.6%.
The range of the Relative Valuation is 11.98 - 20.19 USD.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 8.8x | 8.0x |
| Forward P/E multiples | 10.6x - 17.6x | 14.1x |
| Fair Price | 11.98 - 20.19 | 14.82 |
| Upside | -81.1% - -68.1% | -76.6% |
| Date | P/E |
| 2024-07-26 | 37.38 |
| 2024-07-25 | 36.66 |
| 2024-07-24 | 37.39 |
| 2024-07-23 | 38.26 |
| 2024-07-22 | 36.69 |
| 2024-07-19 | 36.76 |
| 2024-07-18 | 36.26 |
| 2024-07-17 | 37.22 |
| 2024-07-16 | 37.96 |
| 2024-07-15 | 37.37 |
| 2024-07-12 | 37.53 |
| 2024-07-11 | 37.98 |
| 2024-07-10 | 36.87 |
| 2024-07-09 | 36.26 |
| 2024-07-08 | 36.86 |
| 2024-07-05 | 36.31 |
| 2024-07-03 | 35.95 |
| 2024-07-02 | 37.02 |
| 2024-07-01 | 37.50 |
| 2024-06-28 | 37.64 |
| 2024-06-27 | 37.29 |
| 2024-06-26 | 38.71 |
| 2024-06-25 | 37.94 |
| 2024-06-24 | 37.13 |
| 2024-06-21 | 34.59 |
| 2024-06-20 | 35.10 |
| 2024-06-18 | 35.90 |
| 2024-06-17 | 36.52 |
| 2024-06-14 | 37.01 |
| 2024-06-13 | 37.38 |
| 2024-06-12 | 37.95 |
| 2024-06-11 | 38.38 |
| 2024-06-10 | 38.41 |
| 2024-06-07 | 39.45 |
| 2024-06-06 | 40.68 |
| 2024-06-05 | 39.60 |
| 2024-06-04 | 38.28 |
| 2024-06-03 | 37.50 |
| 2024-05-31 | 38.36 |
| 2024-05-30 | 37.51 |
| 2024-05-29 | 37.28 |
| 2024-05-28 | 37.37 |
| 2024-05-24 | 36.24 |
| 2024-05-23 | 35.68 |
| 2024-05-22 | 36.44 |
| 2024-05-21 | 36.47 |
| 2024-05-20 | 36.49 |
| 2024-05-17 | 36.31 |
| 2024-05-16 | 37.69 |
| 2024-05-15 | 38.31 |